Lung Neoplasms: all 7,334 studies

Page 41 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.

• Cryoablation Combined With Camrelizumab and Apatinib for Multiprimary Lung CancerStatus unknownNCT04201990Phase 1/2
• Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)Active, not recruitingNCT04200534Early Phase 1
• WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System MetastasesActive, not recruitingNCT04197934Phase 1
• Neoadjuvant Therapy in Resectable Non-Small Cell Lung Cancer Stages IIB-IIIBStatus unknownNCT04197076
• Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLCStatus unknownNCT04193098Phase 1
• Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung CancerStatus unknownNCT04192682Phase 2/3
• Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung CarcinomaCompletedNCT04189679
• Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLCStatus unknownNCT04189094Phase 2
• Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung CancerCompletedNCT04187768
• [18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed TherapyWithdrawnNCT04186988Early Phase 1
• Lung Cancer Rehabilitation After Medical TreatmentSuspendedNCT04185467Not applicable
• Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the LungCompletedNCT04182815
• Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLCStatus unknownNCT04182698Phase 1/2
• Bronchoscopic ICG Injection and Percutaneous Hook-wire Techniques for Preoperative Lung Nodule Localization in VATSStatus unknownNCT04182152Not applicable
• A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung CancerStatus unknownNCT04181372Phase 2
• Prospective Clinicogenomic ProgramCompletedNCT04180176Phase 4
• Second Primary Lung Cancer Cohort Study (SPORT)Status unknownNCT04178889
• Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant MesotheliomaTerminatedNCT04173338Phase 1
• Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung CancerTerminatedNCT04173325Phase 1
• SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung CancerTerminatedNCT04171284Phase 3
• Watchful Observation of Patients With LD-SCLC Instead of the PCIStatus unknownNCT04168281Not applicable
• A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLCStatus unknownNCT04167774Phase 2
• Evaluation of AL3818 in Combination With Nivolumab in Solid TumorsActive, not recruitingNCT04165330Phase 1/2
• Fluid Biopsy for the Diagnosis of Lung CancerTerminatedNCT04162678
• Green Tea Combined With Chemotherapy in the Treatment of Advanced Non-small Cell Lung CancerWithdrawnNCT04160559Not applicable
• Post SBRT Pulmonary Metastasectomy (PSPM) TrialStatus unknownNCT04160143Not applicable
• NGS-based Large-panel in Targeted Drug Delivery and Immunotherapy of Lung CancerStatus unknownNCT04159337
• Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT04153799Phase 1
• Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLCStatus unknownNCT04153734Phase 2
• LUCID - LUng Cancer CIrculating Tumour Dna StudyStatus unknownNCT04153526
• A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and ChemotherapyWithdrawnNCT04151563Phase 1/2
• Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive, not recruitingNCT04147494Early Phase 1
• Toripalimab Combined With Double Platinum-based Chemotherapy for Initially Unresectable NSCLCCompletedNCT04144608Phase 2
• Sintilimab Combined With Docetaxel for Standard Chemotherapy Failure Non-driver Gene Mutation Metastatic Non-small Cell Lung CancerCompletedNCT04144582Phase 2
• Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene MutationStatus unknownNCT04137718
• Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung CancerStatus unknownNCT04137588
• Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLCStatus unknownNCT04133337Phase 1/2
• Phase II Study With Cabozantinib in Patients With RET Positive NSCLCStatus unknownNCT04131543Phase 2
• Appatinib Combined With S-1 in the Treatment of Small Cell Lung CancerStatus unknownNCT04128800Phase 2
• Clinical Evaluation of Vagal Nerve Preservation in Minimally Invasive Surgery for Early Lung CancerStatus unknownNCT04125979Not applicable
• Arsenic Exposure and Lung Cancer IncidenceCompletedNCT04125381
• Endobronchial Ultrasound-Guided Transbronchial Needle-Aspiration With Suction in Obtaining Samples From Patients With Suspected Nodal Metastatic Lung CancerCompletedNCT04116970Not applicable
• A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung CancerStatus unknownNCT04111913Phase 2
• Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung CancerCompletedNCT04111705Phase 2
• Immunotherapy in Patient With Poor General ConditionCompletedNCT04108026Phase 2
• A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLCStatus unknownNCT04108013Phase 2
• Lifestyle Modification Program for Lung Cancer Patients - A Pilot StudyStatus unknownNCT04105647Not applicable
• Lifestyle Modification Program for Lung Cancer Patients - Physical Activity PreferenceStatus unknownNCT04104516
• Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung CancerActive, not recruitingNCT04093167Phase 2/3
• Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung CancerActive, not recruitingNCT04092283Phase 3
• Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation TherapyActive, not recruitingNCT04085250Phase 2
• Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family CaregiversWithdrawnNCT04085081Not applicable
• MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung CancerStatus unknownNCT04082182Phase 1
• Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT StudyCompletedNCT04081779Not applicable
• Microbiome in Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases, Lung Cancer and HemoptysisCompletedNCT04079400
• MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung CancerCompletedNCT04078269Phase 1
• Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility StudyCompletedNCT04074460Phase 4
• Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung CancerActive, not recruitingNCT04073745Phase 1
• Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung CancerStatus unknownNCT04073550Phase 3
• Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung CancerStatus unknownNCT04073537Phase 3
• Sleep and Immune Checkpoint InhibitorsCompletedNCT04070651
• Adaptive CT Acquisition for Personalised Thoracic ImagingCompletedNCT04070586
• Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLCTerminatedNCT04069936Phase 2
• Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational StudyCompletedNCT04069663
• Descriptors and Predictors of Burden and Information NeedsCompletedNCT04069494
• cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsWithdrawnNCT04069442
• Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS)CompletedNCT04068168
• Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion MutationStatus unknownNCT04063462Phase 2
• Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLCStatus unknownNCT04063449Not applicable
• Efficacy of Continous Regional Anesthesia Using m. Erector Spinae Catheter After VATS ProceduresStatus unknownNCT04062045Not applicable
• Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung CancerWithdrawnNCT04061590Phase 2
• Assessment of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device (Inflammacheck™) in Patients With Interstitial Lung Disease, Lung Cancer and Healthy Volunteers.CompletedNCT04061356
• Pilot Study of SGRT Alone vs. SGRT With Fiducials for Breath Hold SBRT tx of the LungActive, not recruitingNCT04060927Not applicable
• GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaTerminatedNCT04060342Phase 1
• Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]CompletedNCT04059887Phase 4
• Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene SulfonateStatus unknownNCT04059874Phase 1
• Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide ChemotherapyStatus unknownNCT04056949Phase 2
• Assess the Use of rEBUS With a Guide Sheath to Increase Transbronchial Lung Biopsy Yield RateStatus unknownNCT04056273Not applicable
• Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLCCompletedNCT04055792Phase 2
• Study of KN046 With Chemotherapy in First Line Advanced NSCLCStatus unknownNCT04054531Phase 2
• Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung CancerStatus unknownNCT04052412Phase 1
• Comparing the Impact of Multimodal Prehabilitation to Aerobic Training on Patients Undergoing Thoracoscopic LobectomyStatus unknownNCT04049942Not applicable
• Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass NodulesCompletedNCT04047186Phase 2
• Evaluation of NSCLC Patients' Oxygen Uptake On-kinetics at Cycle-ergometer During PrehabilitationCompletedNCT04041297
• A Study of SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer PatientsCompletedNCT04041011Phase 1
• Circulating DNA in Surgically Treated NSCLCStatus unknownNCT04037150
• D-Lung: An Analytics Platform for Lung Cancer Based on Deep Learning TechnologyCompletedNCT04036903
• Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced PneumonitisSuspendedNCT04036721Phase 4
• Study of CT and MR in the Lung CancerStatus unknownNCT04034667
• A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLCActive, not recruitingNCT04033354Phase 3
• Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)CompletedNCT04031898
• Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLCStatus unknownNCT04028778Phase 3
• Phase 2 Study of Dacomitinib in NSCLCActive, not recruitingNCT04027647Phase 2
• The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density.Status unknownNCT04026841Phase 2
• Molecular Profiling ProjectSuspendedNCT04025515
• A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)TerminatedNCT04022876Phase 1
• The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung CancerCompletedNCT04018183
• Biodistribution & Pharmacokinetic of Position Emission Tomography (PET) Radiopharmaceutical 18F C SNAT4SuspendedNCT04017819Phase 1
• Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal CancerStatus unknownNCT04014465
• Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung CancerActive, not recruitingNCT04013542Phase 1

← Lung Neoplasms overview